Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide

Leukemia. 2016 Dec;30(12):2405-2409. doi: 10.1038/leu.2016.228. Epub 2016 Aug 18.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chromosomes, Human, Pair 5
  • Cohort Studies
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lenalidomide
  • Male
  • Middle Aged
  • Mutation
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / genetics
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Young Adult

Substances

  • Immunologic Factors
  • Thalidomide
  • Lenalidomide